Delivery Order SPE2DB22D1002-SPE2DB25FLHB2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Topiramate ER 200 mg capsules (30-count units) under a firm fixed-price contract valued at $5,760.72. This is a non-set-aside competitive award with an ultimate completion date of November 13, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for Topiramate ER 200 mg capsules (30-count units) with a ceiling value of $5,626.87. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of October 21, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,221.18 to AmerisourceBergen Drug Corp for the supply of Topiramate ER 100 mg capsules (30-count units) on October 16, 2025, with an ultimate completion date of October 17, 2025. This is a firm fixed price, non-set-aside contract for delivery to the company's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting the federal government's medical supply needs....
- The Defense Logistics Agency awarded a delivery order valued at $3,471.53 to AmerisourceBergen Drug Corp for the supply of Topiramate ER 100 mg capsules (30-count) with a completion date of October 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on October 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,365.81 to AmerisourceBergen Drug Corp for Topiramate ER 200 mg capsules (30-count units) on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a delivery order valued at $5,717.72 to AmerisourceBergen Drug Corp for the supply of Topiramate ER 200 mg capsules (30-count) on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania location. The order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Topiramate ER 100 mg capsules (30-count units) with a ceiling value of $5,421.03. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is located in Conshohocken, Pennsylvania, the company's headquarters, with an ultimate completion date of August 26, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,523.76 to AmerisourceBergen Drug Corp for Topiramate ER 200 mg capsules (30-count units) on November 13, 2025, with completion scheduled for November 14, 2025. This non-competitive delivery order employs firm fixed-price terms and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply support under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Topiramate ER 50 mg capsules (30-count units) under a firm fixed price contract with a ceiling value of $2,140.45. The delivery order, which is non-competitive and carries an ultimate completion date of August 6, 2025, will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This contract represents a child order against...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,341.04 to AmerisourceBergen Drug Corp for the supply of Topiramate ER 200 mg capsules (30-count units). This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a competitively awarded, non-set-aside contract. The product will be delivered to Conshohocken, Pennsylvania, where the vendor maintains its corporate office. This delivery order operates under...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLHB2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,670.52 on September 2, 2025, for the supply of Topiramate ER 200 mg capsules (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 3, 2025, and performance to be executed from the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a relatively small-value transaction within the broader federal medical procurement landscape, reflecting the pharmaceutical distributor's role in fulfilling tactical supply needs for military healthcare systems. This award is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems globally. The company's contract portfolio encompasses specialty medications, generic drugs, vaccines, and medical devices across multiple therapeutic domains, positioning it as a key supplier within the Defense Logistics Agency's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/2/25 |